Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance

H Yousefi, M Vatanmakanian, M Mahdiannasser… - Oncogene, 2021‏ - nature.com
Integrins are cell adhesion receptors, which are typically transmembrane glycoproteins that
connect to the extracellular matrix (ECM). The function of integrins regulated by biochemical …

Dissecting and rebuilding the glioblastoma microenvironment with engineered materials

KJ Wolf, J Chen, JD Coombes, MK Aghi… - Nature Reviews …, 2019‏ - nature.com
Glioblastoma (GBM) is the most aggressive and common form of primary brain cancer.
Several decades of research have provided great insight into GBM progression; however …

CTSB is a negative prognostic biomarker and therapeutic target associated with immune cells infiltration and immunosuppression in gliomas

K Ma, X Chen, W Liu, S Chen, C Yang, J Yang - Scientific Reports, 2022‏ - nature.com
Previous researches have demonstrated the meaning of CTSB for the progress of several
tumors, whereas few clues about its immunological characteristic in gliomas. Here we …

[HTML][HTML] The interplay between glioblastoma and its microenvironment

M Dapash, D Hou, B Castro, C Lee-Chang, MS Lesniak - Cells, 2021‏ - mdpi.com
GBM is the most common primary brain tumor in adults, and the aggressive nature of this
tumor contributes to its extremely poor prognosis. Over the years, the heterogeneous and …

Targeted theranostic nanoparticles for brain tumor treatment

M Mendes, JJ Sousa, A Pais, C Vitorino - Pharmaceutics, 2018‏ - mdpi.com
The poor prognosis and rapid recurrence of glioblastoma (GB) are associated to its fast-
growing process and invasive nature, which make difficult the complete removal of the …

Diarylureas: Repositioning from antitumor to antimicrobials or multi-target agents against new pandemics

A Catalano, D Iacopetta, M Pellegrino, S Aquaro… - Antibiotics, 2021‏ - mdpi.com
Antimicrobials have allowed medical advancements over several decades. However, the
continuous emergence of antimicrobial resistance restricts efficacy in treating infectious …

ID1high/activin Ahigh glioblastoma cells contribute to resistance to anti-angiogenesis therapy through malformed vasculature

SH Choi, J Jang, Y Kim, CG Park, SY Lee, H Kim… - Cell Death & …, 2024‏ - nature.com
Although bevacizumab (BVZ), a representative drug for anti-angiogenesis therapy (AAT), is
used as a first-line treatment for patients with glioblastoma (GBM), its efficacy is notably …

[HTML][HTML] Musashi-1 enhances glioblastoma migration by promoting ICAM1 translation

JC Lin, JT Tsai, TY Chao, HI Ma, WH Liu - Neoplasia, 2019‏ - Elsevier
Glioblastoma multiforme (GBM) is a lethal brain tumor with a mean survival time of 1 year.
One major reason for therapeutic failure is that GBM cells have an extraordinary capacity to …

IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer

H Yousefi, M Momeny, SH Ghaffari… - Tumori …, 2019‏ - journals.sagepub.com
Introduction: Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy
worldwide and despite an initial response to therapeutic agents, the majority of patients …

Tivozanib mediated inhibition of c-Kit/SCF signaling on Tregs and MDSCs and reversal of tumor induced immune suppression correlates with survival of HCC patients

SG Kalathil, K Wang, A Hutson, R Iyer… - …, 2020‏ - Taylor & Francis
The immune modulatory effect of tivozanib, a tyrosine kinase inhibitor, and the underlying
immune mechanisms impacting survival of HCC patients have not been investigated. Pre …